Holding(s) in Company

RNS Number:8338V
Lombard Medical Technologies PLC
16 December 2005


                           SCHEDULE 10
 
             NOTIFICATION OF MAJOR INTERESTS IN SHARES


1)   NAME OF COMPANY

     LOMBARD MEDICAL TECHNOLOGIES PLC

2)   NAME OF SHAREHOLDER HAVING A MAJOR INTEREST

     AVIVA PLC AND ITS SUBSIDIARIES

3)   Please state whether notification indicates that it is in respect of 
     holding of the Shareholder named in 2 above or in respect of a 
     non-beneficial interest or in the case of an individual holder if it is a
     holding of that person's spouse or children under the age of 18

      AS IN 2 ABOVE

4)   Name of the registered holder(s) and, if more than one holder, the 
     number of shares held by each of them.

     MORLEY FUND MANAGEMENT LTD:
     BNY NORWICH UNION NOMINEES LTD          299,000*
     CHASE GA GROUP NOMINEES LTD           1,216,000*
     CHASE NOMINEES LTD                      126,000*
     CUIM NOMINEE LTD                        319,000*
     
      *DENOTES BENEFICIAL INTEREST 


5)   Number of shares/amount of stock acquired.

     1,960,000

6)   Percentage of issued Class

     4.01%

7)   Number of shares/amount of stock disposed

     N/A

8)   Percentage of issued Class

     N/A

9)   Class of security

     ORD GBP0.02

10)  Date of transaction

     15 DECEMBER 2005

11)  Date company informed

     16 DECEMBER 2005

12)  Total holding following this notification

      1,960,000*

     *BENEFICIAL INTEREST ONLY
               
13)  Total percentage holding of issued class following this notification

      4.01%

14)  Any additional information

      FIGURES ARE BASED ON SHARES IN ISSUE OF 48,893,590

15)  Name of contact and telephone number for queries



16)  Name and signature of authorised company official responsible for 
     making this notification

     Date of Notification ......16 DECEMBER 2005..................


The FSA does not give any express or implied warranty as to the accuracy of this 
document or material and does not accept any liability for error or omission. 
The FSA is not liable for any damages (including, without limitation, damages 
for loss of business or loss of profits) arising in contract, tort or otherwise 
from the use of or inability to use this document, or any material contained in 
it, or from any action or decision taken as a result of using this document or 
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

HOLUNUNRVRRUAAA